SGHF
No.1928 Dong Fang Road, Shanghai, 200125, China
Overview
SGHF is founded in 2016 focusing on investment in growing enterprises of Industry 4.0, IOT industry, Healthcare, Life Science and other high-tech industries in a global context. SGHF has strategic partnerships with listed companies in related industries, state-backed investment funds and financial groups. With its capital and industry resources, SGHF also supports overseas companies' market entry and expansion in Asia Pacific as well as their globalization strategies.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- FitnessGenes
Led · Series A · May 2017
FitnessGenes offers a DNA-testing platform that analyzes multiple gene variations alongside lifestyle and environmental factors to prescribe personalized, week-by-week exercise and nutrition programs. The company’s core product combines peer-validated genetic research with an interpretation engine to reveal traits such as metabolic tendencies, dietary sensitivities, muscle type, fat‑burning capacity and recovery time. FitnessGenes works with academic partners including the Universities of Oxford, Birmingham and Loughborough and is part of an Illumina-led consortia alongside 23andMe. The company has received funding from the UK government’s innovation agency, Innovate UK, and has a patent-pending platform it plans to advance. Management says the Series A proceeds will be used to grow the product offering and expand operations in North America and Europe. FitnessGenes is based in Los Angeles and London and was founded by scientists Dr. Samantha Decombel and Dr. Stuart Grice together with Dr. Dan Reardon and Mark Gilbert.
Team
No current team members are available.